GlassScriptPhysician profile
Melody Salgado
NPI 1629739958
$2,838.94
in general payments reported to CMS, 2019-2025
16 companies · $1,205 in 2025
The $1,205 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $716 · 2023: $566 · 2024: $351 · 2025: $1,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $924.30 | 2022-2025 | Watchman Access System, Watchman Flx, Watchman |
| Shockwave Medical, INC | $546.45 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Aop Health US, LLC | $497.47 | 2025 | Rapiblyk |
| Kiniksa Pharmaceuticals, LTD. | $217.40 | 2022-2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $208.70 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $155.71 | 2022-2025 | Lokelma, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.91 | 2022-2023 | Lifevest |
| Medtronic, INC. | $50.00 | 2023 | Onyx Frontier |
| Janssen Pharmaceuticals, INC | $29.51 | 2024 | Xarelto |
| Novo Nordisk INC | $23.07 | 2024 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.20 | 2022 | |
| Glaxosmithkline, LLC. | $18.03 | 2025 | Shingrix |
| Pfizer INC. | $17.04 | 2023 | |
| Scpharmaceuticals INC. | $14.36 | 2025 | |
| Altathera Pharmaceuticals LLC | $12.67 | 2025 | Sotalol Hydrochloride |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melody Salgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.